Arterial hypertension: ambulatory patients’ point of view. First results of GARANT Study

Aim. To study patients’ awareness on arterial hypertension (AH), its treatment and prevention, as well as to investigate AH therapy compliance, the GARANT Study (PharmacoepidemioloGy of ARteriAl HyperteNsion in Real-World Ambulatory PracTice) was performed, supported by KRKA company. Material and me...

Full description

Saved in:
Bibliographic Details
Main Authors: S. A. Shalnova, A. D. Deev, O. V. Vikhireva
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2007-10-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1320
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839578150158204928
author S. A. Shalnova
A. D. Deev
O. V. Vikhireva
author_facet S. A. Shalnova
A. D. Deev
O. V. Vikhireva
author_sort S. A. Shalnova
collection DOAJ
description Aim. To study patients’ awareness on arterial hypertension (AH), its treatment and prevention, as well as to investigate AH therapy compliance, the GARANT Study (PharmacoepidemioloGy of ARteriAl HyperteNsion in Real-World Ambulatory PracTice) was performed, supported by KRKA company. Material and methods. Doctors and patients from 99 clinics in 63 Russian cities participated in the study. In total, 9214 patients (3189 men, 6025 women; mean age 54,7 years) responded to this doctor-performed survey. Results. AH awareness was high enough, with as many as 86,8% of the patients knowing their blood pressure (BP) level. At the same time, only every third participant knew his or her cholesterol (CH) level. More than 70% of men and 80% of women knew that AH is a risk factor (RF). From the patients’ point of view, AH was the leading RF. Awareness on the other RF was below 33%, with only two exceptions: alcohol (42,2% for men, 35,8% for women) and smoking (38,4% and 30,9%, respectively). Conclusion. While doctors are fully responsible for high BP diagnostics and explanation of pharmaceutical and non-pharmaceutical therapy benefits and risks to their patients, treatment compliance and lifestyle modification should be supported by patients themselves, their families, and society as a whole.
format Article
id doaj-art-db261d3e4e494c5fbfb6eeb2ccce438d
institution Matheson Library
issn 1728-8800
2619-0125
language Russian
publishDate 2007-10-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-db261d3e4e494c5fbfb6eeb2ccce438d2025-08-04T12:50:12Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252007-10-016530331030Arterial hypertension: ambulatory patients’ point of view. First results of GARANT StudyS. A. Shalnova0A. D. Deev1O. V. Vikhireva2State Research Center for Preventive Medicine, State Federal Agency for Health and Social Development; I.M. Sechenov Moscow Medical Academy, MoscowState Research Center for Preventive Medicine, State Federal Agency for Health and Social DevelopmentState Research Center for Preventive Medicine, State Federal Agency for Health and Social DevelopmentAim. To study patients’ awareness on arterial hypertension (AH), its treatment and prevention, as well as to investigate AH therapy compliance, the GARANT Study (PharmacoepidemioloGy of ARteriAl HyperteNsion in Real-World Ambulatory PracTice) was performed, supported by KRKA company. Material and methods. Doctors and patients from 99 clinics in 63 Russian cities participated in the study. In total, 9214 patients (3189 men, 6025 women; mean age 54,7 years) responded to this doctor-performed survey. Results. AH awareness was high enough, with as many as 86,8% of the patients knowing their blood pressure (BP) level. At the same time, only every third participant knew his or her cholesterol (CH) level. More than 70% of men and 80% of women knew that AH is a risk factor (RF). From the patients’ point of view, AH was the leading RF. Awareness on the other RF was below 33%, with only two exceptions: alcohol (42,2% for men, 35,8% for women) and smoking (38,4% and 30,9%, respectively). Conclusion. While doctors are fully responsible for high BP diagnostics and explanation of pharmaceutical and non-pharmaceutical therapy benefits and risks to their patients, treatment compliance and lifestyle modification should be supported by patients themselves, their families, and society as a whole.https://cardiovascular.elpub.ru/jour/article/view/1320arterial hypertensionrisk factorsawarenesstherapycompliance
spellingShingle S. A. Shalnova
A. D. Deev
O. V. Vikhireva
Arterial hypertension: ambulatory patients’ point of view. First results of GARANT Study
Кардиоваскулярная терапия и профилактика
arterial hypertension
risk factors
awareness
therapy
compliance
title Arterial hypertension: ambulatory patients’ point of view. First results of GARANT Study
title_full Arterial hypertension: ambulatory patients’ point of view. First results of GARANT Study
title_fullStr Arterial hypertension: ambulatory patients’ point of view. First results of GARANT Study
title_full_unstemmed Arterial hypertension: ambulatory patients’ point of view. First results of GARANT Study
title_short Arterial hypertension: ambulatory patients’ point of view. First results of GARANT Study
title_sort arterial hypertension ambulatory patients point of view first results of garant study
topic arterial hypertension
risk factors
awareness
therapy
compliance
url https://cardiovascular.elpub.ru/jour/article/view/1320
work_keys_str_mv AT sashalnova arterialhypertensionambulatorypatientspointofviewfirstresultsofgarantstudy
AT addeev arterialhypertensionambulatorypatientspointofviewfirstresultsofgarantstudy
AT ovvikhireva arterialhypertensionambulatorypatientspointofviewfirstresultsofgarantstudy